← Leaderboards
Kenneth C Bagley
Profectus Biosciences, Inc.
$17,138,207
Attributed
$17,936,457
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,936,457 · 15
By mechanism
R44$16,204,494 · 8
R43$1,431,963 · 6
R41$300,000 · 1
Top collaborators
- Deborah L. Fuller3 shared
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesImmune ResponseDna VaccinesAntigensResponseAntibodiesVaccinationVirusSmall Business Innovation Research GrantAdjuvantT Cell ResponseElectroporationMacacaImmunogenicityDoseRegimenT-LymphocytePre-ClinicalLeadImmuneCellsGene GunSiteMucous Membrane
Grant awards (27)
Therapeutic nucleic acid vaccine for chronic hepatitis B in HIV/HBV co-infected individuals$300,000
R41 · FY2025 · AI
Universal Influenza A/B Vaccine$1,000,000
R44 · FY2024 · AI · contact PI
Enhanced Seasonal Influenza Vaccine Targeting Variable and Conserved Antigens$300,000
R44 · FY2024 · AI · contact PI
Universal Influenza A/B Vaccine$998,889
R44 · FY2023 · AI · contact PI
Clinic-Ready MACH-1 Gene Gun for delivery of a universal influenza DNA vaccine$996,500
R44 · FY2023 · AI · contact PI
Next Generation Gene-Gun Delivered DNA and RNA Immunotherapeutic Vaccines for Melanoma.$200,000
R43 · FY2023 · CA · contact PI
Universal Influenza A/B Vaccine$1,000,000
R44 · FY2022 · AI · contact PI
DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine$1,000,000
R44 · FY2021 · AI · contact PI
Development of a rapid response nucleic acid vaccine strategy for coronavirus epidemics$955,395
R44 · FY2021 · AI · contact PI
DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine$1,000,000
R44 · FY2020 · AI · contact PI
Development of a rapid response nucleic acid vaccine strategy for coronavirusepidemics$908,934
R44 · FY2020 · AI · contact PI
Universal Influenza A/B Vaccine$300,000
R44 · FY2020 · AI · contact PI
DNA prime / rVSV boost Multi-Antigen Universal Influenza Vaccine$1,000,000
R44 · FY2019 · AI · contact PI
Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine$569,505
R44 · FY2019 · AI · contact PI
Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine$993,161
R44 · FY2018 · AI · contact PI
Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine$838,478
R44 · FY2017 · AI · contact PI
Novel Mucosal Adjuvant for an HIV DNA Vaccine$793,348
R44 · FY2017 · AI · contact PI
Therapeutic Vaccine for Walnut and Pecan Allergies$241,464
R43 · FY2017 · AI · contact PI
Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine$968,957
R44 · FY2016 · AI · contact PI
Novel Mucosal Adjuvant for an HIV DNA Vaccine$733,632
R44 · FY2016 · AI · contact PI
Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine$998,486
R44 · FY2015 · AI · contact PI
Optimization of a DNA Subunit Regimen for an HIV Vaccine$549,209
R44 · FY2015 · AI · contact PI
Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine$300,000
R44 · FY2014 · AI · contact PI
Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine$238,756
R43 · FY2014 · AI · contact PI
Novel immune stimulating adjuvants for an HIV DNA Vaccine$283,473
R43 · FY2010 · AI · contact PI
Novel Mucosal Adjuvant for an HIV DNA Vaccine$212,099
R43 · FY2010 · AI · contact PI
Universal Influenza DNA vaccine with Novel Toll-Like Receptor Adjuvants$256,171
R43 · FY2008 · AI · contact PI